M&A Buzz In Korea: CJ HealthCare On the Block

CJ Group plans to sell its healthcare affiliate, in what could potentially emerge as the first major M&A deal involving a South Korean pharma firm in recent years. Although the company has not ruled out the option of an initial public offering as an alternative, the sale plan possibly reflects the changing dynamics in the Korean pharma industry.

Incheon_South Korea_1200x675

Leading South Korean food company CJ CheilJedang has hired Morgan Stanley to manage the sale of its wholly-owned subsidiary CJ HealthCare Corp., a mid-size pharma, in what could potentially signal the first major M&A activity in the domestic pharma industry in recent years.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Scrip